Drug class – Bronchodilator
- Significantly reduces airway inflammation and obstruction in chronic stages.
- A better choice than Theophylline for COPD patients having cardiovascular comorbidity.
- Significantly improves cough scoring and sputum quantity in patients with mild persistent asthma.
Drug class – Mucolytic agent
- Facilitates the removal of pulmonary secretions & reduces the viscosity of sputum in both cystic fibrosis and COPD.
- Effectively prevents the Steroid resistant acute exacerbation of Asthma.
- Offers preventive effects against airways hyper-responsiveness.